HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Povidone-iodine

This article was originally published in The Tan Sheet

Executive Summary

Povidone-iodine: 3M submits petition asking FDA to include povidone-iodine acrylate copolymer (.5-1% available iodine) in the OTC health care antiseptic drugs monograph. 3M noted that the health care antiseptics tentative final monograph classified povidone-iodine complex as a Category I (safe and effective) skin preparation ("The Tan Sheet" June 20, 1994, p. 1), and argued that the same factors that determine the safety and efficacy of povidone-iodine complex also cover povidone-iodine acrylate copolymer. 3M said it expects to submit additional data before the end of the comment period...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083997

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel